Syndax Pharmaceuticals, Inc.
SNDX
$19.84
$0.763.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 554.27M | 361.24M | 413.69M | 454.17M | 468.71M |
| Total Receivables | 72.79M | 60.69M | 70.29M | 43.07M | 37.42M |
| Inventory | 41.77M | 43.85M | 39.01M | 27.51M | 20.44M |
| Prepaid Expenses | 3.80M | 3.12M | 3.88M | 4.11M | 3.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.42M | 2.27M | 1.22M | 973.00K | 1.47M |
| Total Current Assets | 675.04M | 471.18M | 528.08M | 529.83M | 531.68M |
|
|
|||||
| Total Current Assets | 675.04M | 471.18M | 528.08M | 529.83M | 531.68M |
| Net Property, Plant & Equipment | 1.29M | 1.39M | 1.52M | 1.60M | 1.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 102.00K | 102.00K | 102.00K | 217.00K | 217.00K |
| Total Assets | 703.65M | 472.67M | 529.71M | 551.79M | 596.15M |
|
|
|||||
| Total Accounts Payable | 4.87M | 10.84M | 16.58M | 13.83M | 17.35M |
| Total Accrued Expenses | 92.75M | 73.57M | 102.34M | 76.51M | 75.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 506.00K | 488.00K | 472.00K | 23.26M | 19.79M |
| Total Finance Division Other Current Liabilities | 1.55M | 1.27M | 721.00K | 595.00K | 618.00K |
| Total Other Current Liabilities | 1.55M | 1.27M | 721.00K | 595.00K | 618.00K |
| Total Current Liabilities | 99.68M | 86.17M | 120.12M | 114.19M | 112.99M |
|
|
|||||
| Total Current Liabilities | 99.68M | 86.17M | 120.12M | 114.19M | 112.99M |
| Long-Term Debt | 588.12M | 343.97M | 343.91M | 320.99M | 324.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 760.00K | 907.00K | 1.05M | 1.19M | 1.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 688.55M | 431.05M | 465.08M | 436.36M | 438.73M |
|
|
|||||
| Common Stock & APIC | 1.61B | 1.59B | 1.57B | 1.55B | 1.53B |
| Retained Earnings | -1.60B | -1.55B | -1.51B | -1.44B | -1.38B |
| Treasury Stock & Other | -140.00K | 11.00K | 452.00K | 525.00K | 285.00K |
| Total Common Equity | 15.10M | 41.62M | 64.63M | 115.43M | 157.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.10M | 41.62M | 64.63M | 115.43M | 157.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.10M | 41.62M | 64.63M | 115.43M | 157.42M |
|
|
|||||